BenevolentAI is an artificial intelligence platform that helps developers build software that can take advantage of unstructured information in scientific papers, patents, clinical trial information, and from a large number of structured data sets.
Focusing on biotechnology, the UK-based startup is focused on helingp discover new drugs to treat conditions like Parkinson's disease and rare cancers.